Jaundice is the primary reason why newborns are readmitted to hospitals worldwide, and millions are not receiving effective treatment.Award-winning medical device nonprofit D-Rev launched its latest newborn product this year — Brilliance Pro, an advanced version of its Brilliance Classic product from 2012, which treats newborn jaundice with sophisticated phototherapy.
Feedback is an excellent way to determine our strength and weakness. A positive feedback is a powerful tool for any company.
A happy customer shared with us his pleasant experience using our delivery table.
“We have been using the Phoenix DT 100 table for the past two years. Our clinician team find the table comfortable and good to use. We have been witnessing several successful deliveries in the past two years. Recently we have delivered 13 babies from 10 deliveries and we would like to give complete credit to Phoenix table for the deliveries”
– Dr. Anbu Chezhian , Vriksham Fertility Centre
Such feedback helps to sustain , improve and enhance our products. It makes our employees feel motivated and strive harder towards our vision.
India is home to the largest population of visually challenged people in the World (2011 census). Visually challenged people face fundamental challenges in mobility, education, employment and an independent living, which ultimately impact their inclusion and integration into the society.
Many companies target the world’s emerging middle-class consumers. Fewer mirror nonprofit D-Rev, which aims to improve the health and lives of people living on less than $4 a day.
Devi’s baby girl was suffering from severe jaundice, and after 3 days under a CFL device at a government hospital in Tamil Nadu, India, her baby showed no improvement. Then, the baby was moved to a double-sided Brilliance device and within 4 days, her bilirubin levels were back to normal. To Devi’s relief, her daughter was finally out of danger.
Efforts to bring promising health care interventions to resource-constrained regions of the world often falter—or even fail—because entrepreneurs underestimate the array of obstacles that loom in their path. Aspiring health innovators can benefit from lessons that some of their predecessors have learned the hard way.
D-Rev, a non-profit based in the United States’ Silicon Valley, designs and delivers products to improve the lives of people living on less than US$4 a day.
The Bay Area-based non-profit technology design firm D-Rev has inked its largest distribution deal since launching in 2007.
D-Rev—co-founded by Paul Polak—announced today that Phoenix Medical Systems in India will run the marketing and distribution of D-Rev’s Brilliance product, a neo-natal phototherapy device used to treat infants with the brain-damaging disease, jaundice, and which comes at a price tag of $400 instead of the usual $3,000.